Protein Profiling Assays Diagnose Periprosthetic Joint Infection
By LabMedica International staff writers Posted on 05 Oct 2011 |
Molecular markers found in the protein in synovial fluid may aid in the diagnosis of patients undergoing revision arthroplasty for septic or aseptic failure.
Proteomic analysis has the potential as highly sensitive diagnostic tool for periprosthetic joint infection (PJI) that occur during surgical reconstruction or replacement of a malformed or degenerated joint.
Doctors at the Thomas Jefferson University Hospital (Philadelphia, PA, USA) collected synovial fluid specimens from selected patients in the operating room at the time of revision surgery and before incision into the joint (arthrotomy). Samples were assayed to determine the concentration of inflammatory proteins according to MultiAnalyte profiling (MAP) protocols established by Rules-Based Medicine (RBM; Austin, TX, USA). The samples were shipped to RBM for Human Inflammation MAP analysis, which quantifies concentrations of 46 inflammatory proteins in fluid samples using a multiplex enzyme-linked immunosorbent assay (ELISA) protocol.
The scientists analyzed 74 synovial fluid samples: 31 infected and 43 uninfected, based on clinical and laboratory criteria. Proteomics analysis and receiver operating characteristic curve analyses were conducted on 46 inflammatory proteins for each sample. Of the 46 proteins, 5 including interleukin 6, interleukin 8, alpha (2)-macroglobulin, C-reactive protein, and vascular endothelial growth factor had an area under the curve greater than 0.90, indicating their importance in infected joints. Of the infected cases, purulence was identified intraoperatively in 22 cases, and an organism was isolated preoperatively or intraoperatively in 16 cases. The organisms isolated included primarily Staphylococcus and Streptococcus species.
The study demonstrated that inflammatory proteins can be detected in synovial fluid and their concentrations ascertained, and these varying concentrations align well with the presence or absence of PJI. The study was published in September 2011, in the Journal of Arthroplasty.
Related Links:
Thomas Jefferson University Hospital
Rules-Based Medicine
Proteomic analysis has the potential as highly sensitive diagnostic tool for periprosthetic joint infection (PJI) that occur during surgical reconstruction or replacement of a malformed or degenerated joint.
Doctors at the Thomas Jefferson University Hospital (Philadelphia, PA, USA) collected synovial fluid specimens from selected patients in the operating room at the time of revision surgery and before incision into the joint (arthrotomy). Samples were assayed to determine the concentration of inflammatory proteins according to MultiAnalyte profiling (MAP) protocols established by Rules-Based Medicine (RBM; Austin, TX, USA). The samples were shipped to RBM for Human Inflammation MAP analysis, which quantifies concentrations of 46 inflammatory proteins in fluid samples using a multiplex enzyme-linked immunosorbent assay (ELISA) protocol.
The scientists analyzed 74 synovial fluid samples: 31 infected and 43 uninfected, based on clinical and laboratory criteria. Proteomics analysis and receiver operating characteristic curve analyses were conducted on 46 inflammatory proteins for each sample. Of the 46 proteins, 5 including interleukin 6, interleukin 8, alpha (2)-macroglobulin, C-reactive protein, and vascular endothelial growth factor had an area under the curve greater than 0.90, indicating their importance in infected joints. Of the infected cases, purulence was identified intraoperatively in 22 cases, and an organism was isolated preoperatively or intraoperatively in 16 cases. The organisms isolated included primarily Staphylococcus and Streptococcus species.
The study demonstrated that inflammatory proteins can be detected in synovial fluid and their concentrations ascertained, and these varying concentrations align well with the presence or absence of PJI. The study was published in September 2011, in the Journal of Arthroplasty.
Related Links:
Thomas Jefferson University Hospital
Rules-Based Medicine
Latest Clinical Chem. News
- Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
- Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
- AI-Powered Raman Spectroscopy Method Enables Rapid Drug Detection in Blood
- Novel LC-MS/MS Assay Detects Low Creatinine in Sweat and Saliva
- Biosensing Technology Breakthrough Paves Way for New Methods of Early Disease Detection
- New Saliva Test Rapidly Identifies Paracetamol Overdose
- POC Saliva Testing Device Predicts Heart Failure in 15 Minutes
- Screening Tool Detects Multiple Health Conditions from Single Blood Drop
- Integrated Chemistry and Immunoassay Analyzer with Extensive Assay Menu Offers Flexibility, Scalability and Data Commutability
- Rapid Drug Test to Improve Treatment for Patients Presenting to Hospital
- AI Model Detects Cancer at Lightning Speed through Sugar Analyses
- First-Ever Blood-Powered Chip Offers Real-Time Health Monitoring
- New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections
- 3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
- POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
- Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
Channels
Molecular Diagnostics
view channel
Blood Test Rules Out Future Dementia Risk
Previous studies have suggested that specific biomarkers, such as tau217, Neurofilament Light (NfL), and Glial Fibrillary Acidic Protein (GFAP), may be valuable for early dementia diagnosis.... Read more
D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism
Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read more
Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions
In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read moreMicrobiology
view channel
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read moreInnovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
Each year, 11 million people across the world die of sepsis out of which 1.3 million deaths are due to antibiotic-resistant bacteria. The burden of antimicrobial resistance (AMR) continues to weigh heavily,... Read more
Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
Acute infectious gastroenteritis results in approximately 179 million cases each year in the United States, leading to a significant number of outpatient visits and hospitalizations. To address this, a... Read morePathology
view channel
AI Model Predicts Patient Response to Bladder Cancer Treatment
Each year in the United States, around 81,000 new cases of bladder cancer are diagnosed, leading to approximately 17,000 deaths annually. Muscle-invasive bladder cancer (MIBC) is a severe form of bladder... Read more
New Laser-Based Method to Accelerate Cancer Diagnosis
Researchers have developed a method to improve cancer diagnostics and other diseases. Collagen, a key structural protein, plays various roles in cell activity. A novel multidisciplinary study published... Read more
New AI Model Predicts Gene Variants’ Effects on Specific Diseases
In recent years, artificial intelligence (AI) has greatly enhanced our ability to identify a vast number of genetic variants in increasingly larger populations. However, up to half of these variants are... Read more
Powerful AI Tool Diagnoses Coeliac Disease from Biopsy Images with Over 97% Accuracy
Coeliac disease is an autoimmune disorder triggered by the consumption of gluten, causing symptoms such as stomach cramps, diarrhea, skin rashes, weight loss, fatigue, and anemia. Due to the wide variation... Read moreTechnology
view channel
Smartphones Could Diagnose Diseases Using Infrared Scans
Rapid advancements in technology may soon make it possible for individuals to bypass invasive medical procedures by simply uploading a screenshot of their lab results from their phone directly to their doctor.... Read more
Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
Metabolites are critical compounds that fuel life's essential functions, playing a key role in producing energy, regulating cellular activities, and maintaining the balance of bodily systems.... Read more
3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
Microfluidic devices are diagnostic systems capable of analyzing small volumes of materials with precision and speed. These devices are used in a variety of applications, including cancer cell analysis,... Read moreIndustry
view channel
New Collaboration to Advance Microbial Identification for Infectious Disease Diagnostics
With the rise of global pandemics, antimicrobial resistance, and emerging pathogens, healthcare systems worldwide are increasingly dependent on advanced diagnostic tools to guide clinical decisions.... Read more